Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.
Vous n'êtes pas connecté
Novavax and Alnylam are in the spotlight following drug approval and regulatory updates, respectively.
Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.
Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.
Gilead Sciences and Nuvalent are in the spotlight following positive updates on key candidates.
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best...
Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according...
Providers of vaccines against African swine fever (ASF) from four countries are seeking the Food and Drug Administration’s (FDA) approval, according...
Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Thursday. The...
Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...
The Food and Drug Administration (FDA), as many are aware, is the leading entity for the regulation and safety testing for foods and pharmaceuticals...